Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Secures Ethics Approval for Phase 3 Trial

Feb 24, 2025 at 2:27 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment